Evidence map›Paper›PMID 31548718›Full record

ArticleNature genetics2019

H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines.

Tobias Hofving, Joakim Karlsson, Ola Nilsson, Jonas A Nilsson

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Transcriptomic Profiling ofFrontiers in oncology · 2021
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Tobias Hofving *Department of Laboratory Medicine, Sahlgrenska Cancer Center, Institute of Biomedicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-9855-4268
Joakim Karlsson *Sahlgrenska Translational Melanoma Group, Department of Surgery, Sahlgrenska Cancer Center, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-6332-4043
Ola NilssonDepartment of Laboratory Medicine, Sahlgrenska Cancer Center, Institute of Biomedicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. ola.nilsson@llcr.med.gu.se.
Jonas A NilssonSahlgrenska Translational Melanoma Group, Departments of Surgery and Oncology, Sahlgrenska Cancer Center, Institute of Clinical Sciences, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden. Jonas.a.nilsson@surgery.gu.se.ORCID http://orcid.org/0000-0003-0346-6837

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neuroendocrine TumorsPrecision MedicineCell LineHumansMedical Oncology

Identifiers

PMID31548718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.